Recent clinical data has shown that the use of an embolic protection device during interventional procedures, especially SVG angioplasties, greatly reduces the occurrence of complications such as strokes. The reason for this is that strokes after interventional procedures are usually caused by the dislodging of plaque attached to the vessel wall that travel through the vasculature and cause a blockage in a smaller vessel.
Table of Contents
1. RESEARCH METHODOLOGYStep 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecasts and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
2. DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE TREATMENTS AND DIAGNOSTICS
2.2.1 General Diagnostics
2.2.2 Coronary Artery Disease (CAD)
2.2.3 Myocardial Infarction (MI)
2.2.4 Angina Pectoris
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Statistics
3. CORONARY EMBOLIC PROTECTION DEVICE MARKET
3.1 INTRODUCTION
3.1.1 Saphenous Vein Grafts
3.1.2 Protection Mechanism
3.1.2.1 Filter Basket
3.1.2.2 Distal Balloon Occlusion
3.2 MARKET ANALYSIS AND FORECAST
3.3 DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE MARKET SHARE ANALYSIS
Abbreviations
Appendix I: Company Press Releases
List of Charts:
Chart 1 1: Interventional Cardiology Device Market by Segment, U.S., 2014 – 2024
Chart 1 2: Interventional Cardiology Device Market Overview, U.S., 2017 & 2024
Chart 3 1: Coronary Embolic Protection Device Market, U.S., 2014 – 2024
Chart 3 2: Leading Competitors, Coronary Embolic Protection Device Market, U.S., 2017
List of Figures:
Figure 1 1: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (1 of 3)
Figure 1 2: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (2 of 3)
Figure 1 3: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (3 of 3)
Figure 1 4: Companies Researched in this Report, U.S., 2017
Figure 1 5: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (1 of 3)
Figure 1 6: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (2 of 3)
Figure 1 7: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (3 of 3)
Figure 1 8: Recent Events in the Interventional Cardiology Market, U.S., 2014 – 2017
Figure 1 9: Interventional Cardiology Procedures Covered, U.S., 2017
Figure 1 10: Procedure Codes Investigated, U.S., 2017
Figure 1 11: Interventional Cardiology Markets Covered, U.S., 2017 (1 of 2)
Figure 1 12: Interventional Cardiology Markets Covered, U.S., 2017 (2 of 2)
Figure 1 13: Key Report Updates
Figure 1 14: Version History
Figure 3 1: Coronary Embolic Protection Device Market, U.S., 2014 – 2024
Figure 3 2: Drivers and Limiters, Coronary Embolic Protection Device Market, U.S., 2017
Figure 3 3: Leading Competitors, Coronary Embolic Protection Device Market, U.S., 2017
Figure 5 1: Press Release Summary
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific
- Abbott Laboratories
- Medtronic
- Philips
- Terumo
- Cardinal Health
- Merit Medical Systems
- Cook Medical
- Asahi Intecc
- Teleflex
- Cardiovascular Systems Inc.
- Galt Medical
- C.R. Bard
- Angiodynamics
- ACIST Medical Systems
- Infraredx
- Tryton Medical
- B. Braun
- Maquet
Please Note: Not all companies are currently active in every segment or sub-report from this suite.
